| |
About NCCN
The National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives.
World-renowned experts from NCCN Member Institutions diagnose and treat patients with a broad spectrum of cancers and are recognized for dealing with complex, aggressive, or rare cancers. More than 160,000 new patients receive cancer care at NCCN Member Institutions over the course of any year. NCCN Member Institutions pioneered the concept of the multidisciplinary team approach to patient care and lead the fight against cancer as they integrate programs in patient care, research, and education. Our programs offer access to expert physicians, superior treatment, and quality and safety initiatives that continuously improve the effectiveness and efficiency of cancer care. Thirty-seven Nobel Prize winners have served on the faculties of NCCN Member Institutions.
The National Comprehensive Cancer Network (NCCN) is a 501(c)3 not-for-profit alliance of 21 of the world’s leading cancer centers. All NCCN Member Institutions are not-for-profit organizations. NCCN and its Member Institutions are dedicated to improving the quality and effectiveness of care provided to patients with cancer. NCCN develops scientific, evaluative information to inform and improve decisions that can lead to better care. The development of NCCN information is based upon the independent evaluation of available scientific evidence integrated with the expert judgment of leading clinicians.
The National Comprehensive Cancer Network is an alliance of 21 of the world’s leading cancer centers, working together to develop treatment guidelines for most cancers, and dedicated to research that improves the quality, effectiveness, and efficiency of cancer care. NCCN offers a number of programs to give clinicians access to tools and knowledge that can help guide decision-making in the management of cancer.
Interested parties may submit scientific data to NCCN for consideration by the guidelines panels at their review meetings. In order to facilitate timely submission of information, NCCN has posted a tentative meeting schedule.
NCCN News includes all the latest announcements about NCCN programs, educational materials and upcoming events as well as recent press coverage.
NCCN’s Board of Directors is comprised of key leadership from each of the 21 NCCN Member Institutions. Led by Al B. Benson III, MD, from Robert H. Lurie Comprehensive Cancer Center of Northwestern University, this group provides oversight for NCCN activities. NCCN CEO, William T. McGivney, PhD, provides overall direction for the organization.
NCCN is an Equal Opportunity Employer in a significant growth phase. If you would like to become part of our premier organization dedicated to developing programs and products to enhance cancer care, please see our employment opportunities. We offer competitive salaries and excellent benefits.
Please go to our Permission Request Section to submit a request.
The NCCN Member Institutions are:
- City of Hope, Los Angeles, CA
- Dana-Farber/Brigham and Women’s Cancer Center
Massachusetts General Hospital Cancer Center, Boston, MA
- Duke Comprehensive Cancer Center, Durham, NC
- Fox Chase Cancer Center, Philadelphia, PA
- Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT
- Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA
- Arthur G. James Cancer Hospital & Richard J. Solove Research Institute at The Ohio State University, Columbus, OH
- The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL
- Memorial Sloan-Kettering Cancer Center, New York, NY
- H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
- Roswell Park Cancer Institute, Buffalo, NY
- Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO
- St. Jude Children's Research Hospital/University of Tennessee Cancer Institute, Memphis, TN
- Stanford Comprehensive Cancer Center, Stanford, CA
- University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA
- University of Michigan Comprehensive Cancer Center, Ann Arbor, MI
- UNMC Eppley Cancer Center at The Nebraska Medical Center, Omaha, NE
- The University of Texas M. D. Anderson Cancer Center, Houston, TX
- Vanderbilt-Ingram Cancer Center, Nashville, TN
|
|